Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Wyeth-Ayerst seeks European approval of Rapamune

Feb. 18, 1999

Good safety, increased immunogenicity reported for MF59-adjuvanted flu vaccine

Feb. 12, 1999

ID Biomedical and Ribi ImmunoChem to develop E. coli vaccine

Feb. 11, 1999

DTaP-IPV vaccine receives marketing authorization in Germany

Feb. 11, 1999

Adjuvants and immunoeffectors from AGP series under evaluation at Ribi

Feb. 9, 1999

NIH seeks licensees and/or CRADA partners for development of HCV vaccine

Feb. 9, 1999

Novartis describes new PNP inhibitor series in recent patent literature

Feb. 8, 1999

Novel ferrioxamine immunosuppressant discovered at Japanese research institutes

Feb. 5, 1999

Abgenix reports positive preliminary results from phase II trial of GVHD treatment

Feb. 5, 1999

EMEA marketing approval for Triacelluvax

Feb. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...